Sheng Ding
Country:
China
Company:
Investigator and Professor at Gladstone Institute of Cardiovascular Disease, and Department of Pharmaceutical Chemistry, University of California San Francisco
His research primarily revolves around the field of chemical biology, stem cell biology, and drug discovery. Sheng Ding is well-known for his pioneering work on small molecule compounds and their impact on cellular reprogramming, which has significant implications for regenerative medicine and disease modeling.